Alivus Life Sciences Ltd
Board Meeting Intimation for Inter Alia To Consider And Approve The Unaudited Financial Results Of The Company For The Third Quarter And Nine Months Ended 31St December 2024
03:51 PM, 16th Jan 2025
Glenmark Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/01/2025 inter alia to consider and approve the Unaudited Financial Results of the Company for the third quarter and nine months ended 31st December 2024.
